share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Aug 2 16:29

Summary by Moomoo AI

Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,220 shares of common stock on 08/02/2024, as per the latest filing. The shares, valued at an aggregate market price of $47,063, were acquired on 08/01/2024 through a restricted stock vest from the company itself. This transaction follows a previous sale of 1,775 shares by Matsuda in the past three months, which had gross proceeds of $15,988.
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,220 shares of common stock on 08/02/2024, as per the latest filing. The shares, valued at an aggregate market price of $47,063, were acquired on 08/01/2024 through a restricted stock vest from the company itself. This transaction follows a previous sale of 1,775 shares by Matsuda in the past three months, which had gross proceeds of $15,988.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more